Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease

Emerging Infectious Diseases

Volumn 22, Issue 3, 2016, Pages 365-369

  Raju, Ravikiran M ^a   Raju, Sagar M ^a   Zhao, Yanlin ^b   Rubin, Eric J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BEDAQUILINE; CLARITHROMYCIN; DELAMANID; TUBERCULOSTATIC AGENT;

ARTICLE; ATYPICAL MYCOBACTERIUM; CLINICAL TRIAL (TOPIC); CYSTIC FIBROSIS; DIAGNOSTIC ERROR; DISEASE TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HUMAN; MOLECULAR TYPING; NONHUMAN; PREVALENCE; SPECIES DIFFERENTIATION; SPUTUM SMEAR; TUBERCULOSIS; DIET THERAPY; MEDICAL RESEARCH; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BIOMEDICAL RESEARCH; HUMANS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; TUBERCULOSIS;

EID: 84958824680     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2203.151643     Document Type: Article

References (19)

1. Holland SM. Nontuberculous mycobacteria. Am J Med Sci. 2001; 321:49-55. http://dx.doi.org/10.1097/00000441-200101000-00008.
2. Pokam BT, Asuquo AE. Acid-fast bacilli other than mycobacteria in tuberculosis patients receiving directly observed therapy short course in Cross River State, Nigeria. Tuberc Res Treat. 2012, 2012: 301056. http://dx.doi.org/10.1155/2012/301056.
3. Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, et al. Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. Zhou D, editor. PLoS ONE. 2013;8:e63170. http://dx.doi.org/10.1371/journal.pone.0063170.
4. Turnbull E, Siyamabango M, Kaunda K, Chileshe C, Dunn I, Reid S, et al. Clinical characterization of symptomatic patients with non-tuberculous mycobacteria in Zambian prisons [poster abstract]. Presented at: 44thh Union World Conference on Lung Health; 2013 Oct 31-Nov 4; Paris, France.
5. de Mello KGC, Mello FCQ, Borga L, Rolla V, Duarte RS, Sampaio EP, et al. Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011. Emerg Infect Dis. 2013;19:393-9. http://dx.doi.org/10.3201/eid/1903.120735.
6. Maiga M, Siddiqui S, Diallo S, Diarra B, Traoré B, Shea YR, et al. Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis. Hozbor DF, editor. PLoS ONE. 2012;7:e36902. http://dx.doi.org/10.1371/journal.pone.0036902.
7. Shahraki AH, Heidarieh P, Bostanabad SZ, Khosravi AD, Hashemzadeh M, Khandan S, et al. “Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria. Eur J Intern Med. 2015;26:279-84. http://dx.doi.org/10.1016/j.ejim.2015.03.001.
8. Poyntz HC, Stylianou E, Griffiths KL, Marsay L, Checkley AM, McShane H. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb). 2014;94:226-37 http://dx.doi.org/10.1016/j.tube.2013.12.006.
9. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416. http://dx.doi.org/10.1164/rccm.200604-571ST.
10. Wallace RJ, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med. 1994;149:1335-41. http://dx.doi.org/10.1164/ajrccm.149.5.8173775.
11. Huang JH, Kao PN, Adi V, Ruoss SJ. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest. 1999;115:1033-40. http://dx.doi.org/10.1378/chest.115.4.1033.
12. Nash KA, Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother. 1995;39:2625-30. http://dx.doi.org/10.1128/AAC.39.12.2625.
13. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. 2013;381:1551-60. http://dx.doi.org/10.1016/S0140-6736(13)60632-7.
14. Thomson R, Tolson C, Carter R, Coulter C, Huygens F, Hargreaves M. Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol. 2013;51:3006-11. http://dx.doi.org/10.1128/JCM.00899-13.
15. Philley JV, Wallace RJ, Benwill JL, Taskar V, Brown-Elliott BA, Thakkar F, et al. Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease. Chest. 2015; 148:499-506. http://dx.doi.org/10.1378/chest.14-2764.
16. Ji B, Lefrancois S, Robert J, Chauffour A, Truffot C, Jarlier V. In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans. Antimicrob Agents Chemother. 2006; 50:1921-6. http://dx.doi.org/10.1128/AAC.00052-06.
17. Vera-Cabrera L, Brown-Elliott BA, Wallace RJ, Ocampo-Candiani J, Welsh O, Choi SH, et al. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. Antimicrob Agents Chemother. 2006;50:4027-9. http://dx.doi.org/10.1128/AAC.00763-06.
18. Balemans W, Vranckx L, Lounis N, Pop O, Guillemont J, Vergauwen K, et al. Novel antibiotics targeting respiratory ATP synthesis in gram-positive pathogenic bacteria. Antimicrob Agents Chemother. 2012;56:4131-9. http://dx.doi.org/10.1128/AAC.00273-12.
19. Tateishi Y, Kitada S, Miki K, Maekura R, Ogura Y, Ozeki Y, et al. Whole-genome sequence of the hypervirulent clinical strain Mycobacterium intracellulare M.i.198. J Bacteriol. 2012;194:6336. http://dx.doi.org/10.1128/JB.01439-12.